Immuneering Corporation (IMRX)
undefined
undefined%
At close: undefined
1.60
-2.44%
After-hours Dec 13, 2024, 07:58 PM EST

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -0.98 -0.65 -3.17 -6.58 -13.92
PS Ratio 0.00 100.94 51.15 48.54 58.45
PB Ratio 0.58 0.29 0.68 -4.99 -17.19
P/FCF Ratio -1.06 -0.71 -3.44 -7.65 -25.14
P/OCF Ratio -1.07 -0.73 -3.45 -7.67 -25.26
OCF/S Ratio 0.00 -34.79 -3.71 -1.58 -0.58
Debt / Equity Ratio 0.00 0.00 0.00 0.00 -0.64
Quick Ratio 2.84 3.38 6.76 4.18 6.96
Current Ratio 2.84 3.38 6.76 4.18 6.96
Asset Turnover 0.00 0.00 0.01 0.06 0.14
Interest Coverage 0.00 -12.75 0.00 0.00 -4.48
Return on Equity (ROE) -59.03% -44.86% -21.50% 75.80% 123.50%
Return on Assets (ROA) -52.12%-40.27%-20.12%-44.35%-57.17%
Return on Capital (ROIC) -61.66%-45.27%-21.04%-47.23%-46.28%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin 0.00% 12.53% 11.14% 11.15% 9.07%
Net Profit Margin 0.00% -3887.17% -403.08% -184.29% -104.97%